A Comparative Review of Artificial Intelligence Applications in Small Molecule Versus Peptide Drug Discovery. [PDF]
Lin H, Vogel H, Zhang H.
europepmc +1 more source
Computational and immunoinformatics approaches for designing phytocompound-based drugs and a multi-epitope vaccine targeting FemA, a cell wall protein of Staphylococcus aureus. [PDF]
Shuvo MN +6 more
europepmc +1 more source
AI-Driven Design of Miniproteins as Potential Allosteric Modulators. [PDF]
Liu X, Sun Y, Xia Y, Li H, Yan Z.
europepmc +1 more source
A physics-informed graph neural network to approximate docking-based binding affinity for DYRK2 in Alzheimer's drug repurposing. [PDF]
Gider V, Budak C.
europepmc +1 more source
The Biggest Challenge for Prediction of Membrane Permeability of Cyclic Peptides: Scarce Data Availability. [PDF]
Lamers C.
europepmc +1 more source
Large Language Model Agent for Modular Task Execution in Drug Discovery. [PDF]
Ock J +5 more
europepmc +1 more source
Related searches:
Modality-DTA: Multimodality Fusion Strategy for Drug–Target Affinity Prediction
IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2023Prediction of the drug-target affinity (DTA) plays an important role in drug discovery. Existing deep learning methods for DTA prediction typically leverage a single modality, namely simplified molecular input line entry specification (SMILES) or amino acid sequence to learn representations.
Xixi Yang +6 more
openaire +4 more sources
Breaking the barriers of data scarcity in drug–target affinity prediction
Briefings in Bioinformatics, 2023Abstract Accurate prediction of drug–target affinity (DTA) is of vital importance in early-stage drug discovery, facilitating the identification of drugs that can effectively interact with specific targets and regulate their activities. While wet experiments remain the most reliable method, they are time-consuming and resource-intensive,
Qizhi Pei +8 more
openaire +4 more sources

